According to a Reuters article, pharma companies launched new US drugs at prices 35% higher in 2023 compared to those ...

More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...

Pfizer has raised the price of Paxlovid, the anti-COVID medicine, by 3 per cent, the migraine treatment, Nurtec, and cancer ...

NEW YORK CITY, New York: At the start of 2025, drug companies raised prices on over 250 brand-name medications in the U.S., including Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's ...

As well as a 3% hike on Paxlovid, the company raised prices on medicines including migraine treatment Nurtec and cancer drugs ...

It might seem that valuation is no longer important for investors. Stocks that have sky-high valuation metrics continue to ...

Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...

As well as a 3% hike on Paxlovid, the company raised prices on medicines including migraine treatment Nurtec and cancer drugs ...

As well as a 3 percent hike on Paxlovid, the company raised prices on medicines including migraine treatment Nurtec and cancer drugs Adcetris ... support investments in drug development and offset ...